Cutter & CO Brokerage, Inc. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutter & CO Brokerage, Inc. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$11,809
-32.4%
10,180
-12.0%
0.00%
-40.0%
Q1 2023$17,463
-44.8%
11,565
-8.6%
0.01%
-54.5%
Q4 2022$31,638
-41.4%
12,655
-1.9%
0.01%
-45.0%
Q3 2022$54,000
+45.9%
12,905
-1.5%
0.02%
+53.8%
Q2 2022$37,000
-51.9%
13,105
-2.1%
0.01%
-43.5%
Q1 2022$77,000
-48.3%
13,380
-18.0%
0.02%
-43.9%
Q4 2021$149,000
-54.8%
16,325
-47.1%
0.04%
-48.1%
Q3 2021$330,000
-25.3%
30,835
+8.3%
0.08%
-22.5%
Q2 2021$442,000
-2.0%
28,465
+2.2%
0.10%
-7.3%
Q1 2021$451,000
-36.1%
27,840
-16.5%
0.11%
-40.5%
Q4 2020$706,000
+56.2%
33,340
+9.4%
0.18%
+38.1%
Q3 2020$452,000
+1.8%
30,480
+0.9%
0.13%
-7.6%
Q2 2020$444,000
+27.2%
30,205
+1.6%
0.14%
+9.8%
Q1 2020$349,000
-48.2%
29,725
+3.6%
0.13%
-44.3%
Q4 2019$674,000
+62.0%
28,685
+27.4%
0.24%
+76.9%
Q3 2019$416,000
+6.1%
22,510
+6.8%
0.13%
+8.1%
Q2 2019$392,000
+9.5%
21,070
+43.8%
0.12%
+21.6%
Q1 2019$358,000
+21.4%
14,655
+28.7%
0.10%
-8.9%
Q4 2018$295,000
-18.1%
11,3850.0%0.11%
-8.9%
Q3 2018$360,000
-18.6%
11,3850.0%0.12%
-27.6%
Q2 2018$442,000
+50.9%
11,385
+7.2%
0.17%
+46.6%
Q1 2018$293,00010,6200.12%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders